3.5 stars out of 5
Too many characters (made worse because
most have more than one identity), too many plot twists, too much technical information. The result? Way too much of what could have been a good thing. Because of the subject matter - an experimental drug gone wrong - I wanted very much to love this book. But in the end, for the most part, I'm not at all sure I "got" what happened.
That out of the way, I'll try to summarize my thoughts on the plot: Christina Silva, a gorgeous Latina psychiatrist, is participating in a trial of a drug called Recognate on behalf of the manufacturer (a company that appears to be operating off the industry radar). Supposedly, the drug helps regenerate lost memories, or replace bad ones, or both - I think - and so far, it seems to be helping Christina's patients. That is, until it doesn't; suddenly, one patient goes berserk - and then another. Did the drug, which is related to betaendorphins, trigger the aberrant behavior, or did something else happen?
Right about then, Christina is accosted by a nasty looking man who tells her she isn't who she thinks she is. She doesn't believe him, exactly, but part of her own memories - most of which she lost when she was in an auto accident in which her parents were killed - hint that maybe the guy knows what he's talking about. All she's sure of is that she's got a few secrets of her own - most of them lost for the time being, one not that could result in revocation of her license to practice - and she desperately wants to learn the truth about her past.
Along come the cops, notably in the form of local detective Gary Wilson, plus a couple of FBI agents who seem to enjoy playing good cop, bad cop and making life miserable for Wilson. He tends to believe what Christina tells him, though (his opinion bolstered by what could be a fatal attraction to the psychiatrist). Clues point to a clandestine organization called Zero Dark - and from that point on, as Christina tries to find out about her past while dodging bullets (literally), things began to get murkier than they already were.
As I said early on, I really wanted to love this book. And I'm sure if it gets to the right readers, it will be; it's technically well written with a well-researched, timely plot, and I thank the publisher, via NetGalley, for the pre-release copy to read and review. My experience, though, was summed up at the end by Christina (or whoever she really is) as she basically says hey, I'm not sure what went down, but I've determined not to worry about it and just get on with my life.
Yeah. Me too (sigh).
Adverse Effects by Joel Shulkin (Blackstone Publishing, September 2020); 352 pp.